Stock Market Live July 2, 2026: S&P 500 (SPY) Flat with New Jobs Data

Health and Healthcare

Johnson & Johnson : JNJ

All Johnson & Johnson Articles

1243 Articles

Chris Lange | Feb 3, 2018 at 8:50 AM EST

Major Biopharma Catalysts on February’s FDA Calendar

24/7 Wall St. has included a calendar of a some of the biggest companies expecting clinical trial and U.S. Food…

Chris Lange | Jan 27, 2018 at 9:20 AM EST

Top Stocks to Look For in February’s FDA Calendar

Johnson &; Johnson, Gilead Sciences and Amicus Therapeutics are among companies expecting clinical trial and FDA updates in February.

Paul Ausick | Jan 25, 2018 at 4:01 PM EST

Boeing, 3M Dominate DJIA on Thursday

Boeing, 3M, Johnson & Johnson, and United Technologies pushed the DJIA to a triple-digit gain Thursday.

Paul Ausick | Jan 23, 2018 at 4:01 PM EST

Travelers, General Electric Hold DJIA Higher Tuesday

Travelers and General Electric played big roles in helping the Dow finish basically flat Monday. Johnson & Johnson and Procter…

Chris Lange | Jan 23, 2018 at 8:55 AM EST

Johnson & Johnson Takes on $14 Billion Tax Charge With Q4 Earnings

Johnson & Johnson reported better-than-expected fourth-quarter financial results before the markets opened on Tuesday.

Chris Lange | Jan 21, 2018 at 10:15 AM EST

GE, Intel, Verizon and More Dow Earnings Coming This Week

24/7 Wall St. has put together a preview of GE, Intel, Verizon and other Dow Jones Industrial Average companies due…

Paul Ausick | Jan 9, 2018 at 4:01 PM EST

Boeing, General Electric Pace DJIA Gains Tuesday

Boeing, General Electric, Johnson & Johnson, and United Technologies were Tuesday's pacesetters among the Dow 30 stocks.

Chris Lange | Jan 6, 2018 at 8:55 AM EST

20 More Biopharma Catalysts Coming in 2018

Credit Suisse has put together a list of biopharma companies in its coverage universe that stand to make significant moves…

Jon C. Ogg | Jan 3, 2018 at 8:35 AM EST

2018 Bull/Bear Outlook: How All 30 DJIA Stocks Will Take the Market to 26,400 or Higher

Here is a consensus forecast of each of the 30 Dow Jones Industrial stocks, including a forward 12-month consensus analyst…

Jon C. Ogg | Jan 2, 2018 at 9:15 AM EST

Top Analyst Upgrades and Downgrades: Abbott Labs, Delphi, Lululemon, Netflix, Nordstrom, Sirius XM, Disney, Windstream and More

The top analyst upgrades, downgrades and other research calls from Tuesday include Abbott Labs, Delphi, Lululemon, Netflix, Nordstrom, Sirius XM,…

Jon C. Ogg | Dec 26, 2017 at 11:15 AM EST

Meet the Preliminary Dogs of the Dow for 2018

One strategy that has been popular each year as investors rebalance and make changes is the so-called Dogs of the…

Chris Lange | Nov 16, 2017 at 10:35 AM EST

Achillion Pharmaceuticals Gears Up for Secondary Offering

Achillion Pharmaceuticals saw its shares make a handy gain on Thursday after the company announced a secondary offering.

Lee Jackson | Nov 1, 2017 at 10:10 AM EDT

UBS Dividend Ruler Stocks Stay Hot: 4 to Buy for 2018

These are four quality companies that should continue to do well in 2018. Investors to want to buy the shares…

Jon C. Ogg | Oct 18, 2017 at 11:40 AM EDT

Analysts Piling On to Raise Johnson & Johnson Price Targets Higher and Higher

24/7 Wall St. tracks key analyst calls in the stocks that move the markets and which are important to investors.…

Paul Ausick | Oct 17, 2017 at 4:01 PM EDT

UnitedHealth, Johnson & Johnson Lead Dow Higher Tuesday

UnitedHealth, J&J, Nike, and Verizon lifted the DJIA on Tuesday.

1 … 36 37 38 39 40 … 83

Johnson & Johnson : JNJ

All Johnson & Johnson Articles

Major Biopharma Catalysts on February’s FDA Calendar

Top Stocks to Look For in February’s FDA Calendar

Boeing, 3M Dominate DJIA on Thursday

Travelers, General Electric Hold DJIA Higher Tuesday

Johnson & Johnson Takes on $14 Billion Tax Charge With Q4 Earnings

GE, Intel, Verizon and More Dow Earnings Coming This Week

Boeing, General Electric Pace DJIA Gains Tuesday

20 More Biopharma Catalysts Coming in 2018

2018 Bull/Bear Outlook: How All 30 DJIA Stocks Will Take the Market to 26,400 or Higher

Top Analyst Upgrades and Downgrades: Abbott Labs, Delphi, Lululemon, Netflix, Nordstrom, Sirius XM, Disney, Windstream and More

Meet the Preliminary Dogs of the Dow for 2018

Achillion Pharmaceuticals Gears Up for Secondary Offering

UBS Dividend Ruler Stocks Stay Hot: 4 to Buy for 2018

Analysts Piling On to Raise Johnson & Johnson Price Targets Higher and Higher

UnitedHealth, Johnson & Johnson Lead Dow Higher Tuesday

Stock Market Live July 2, 2026: S&P 500 (SPY) Flat with New Jobs Data

Reddit Vs. Chewy: The Better Buy Stock In 2026

This Cash-Rich Telecom Anchor Is an Unbeatable Haven for Retirees

Will Warsh Cut Rates After a Huge Job Miss?

Dividend Aristocrats Are Quietly Outrunning Software in 2026. Investors Are Piling Into This ETF

$900,000 Inherited 401(k): The 10-Year Tax Bomb Most Beneficiaries Miss Until Year 10

Reddit Vs. Chewy: The Better Buy Stock In 2026

This Cash-Rich Telecom Anchor Is an Unbeatable Haven for Retirees

Johnson & Johnson : JNJ

All Johnson & Johnson Articles

Major Biopharma Catalysts on February’s FDA Calendar

Top Stocks to Look For in February’s FDA Calendar

Boeing, 3M Dominate DJIA on Thursday

Travelers, General Electric Hold DJIA Higher Tuesday

Johnson & Johnson Takes on $14 Billion Tax Charge With Q4 Earnings

GE, Intel, Verizon and More Dow Earnings Coming This Week

Boeing, General Electric Pace DJIA Gains Tuesday

20 More Biopharma Catalysts Coming in 2018

2018 Bull/Bear Outlook: How All 30 DJIA Stocks Will Take the Market to 26,400 or Higher

Top Analyst Upgrades and Downgrades: Abbott Labs, Delphi, Lululemon, Netflix, Nordstrom, Sirius XM, Disney, Windstream and More

Meet the Preliminary Dogs of the Dow for 2018

Achillion Pharmaceuticals Gears Up for Secondary Offering

UBS Dividend Ruler Stocks Stay Hot: 4 to Buy for 2018

Analysts Piling On to Raise Johnson & Johnson Price Targets Higher and Higher

UnitedHealth, Johnson & Johnson Lead Dow Higher Tuesday

Stock Market Live July 2, 2026: S&P 500 (SPY) Flat with New Jobs Data

Reddit Vs. Chewy: The Better Buy Stock In 2026

This Cash-Rich Telecom Anchor Is an Unbeatable Haven for Retirees

Will Warsh Cut Rates After a Huge Job Miss?

Featured Reads

Dividend Aristocrats Are Quietly Outrunning Software in 2026. Investors Are Piling Into This ETF

$900,000 Inherited 401(k): The 10-Year Tax Bomb Most Beneficiaries Miss Until Year 10